Technology Summary
A novel method of treatment has been identified by OHSU researchers that has the potential to effectively treat HER-2 positive breast cancer. The approach involves using an antibody that is capable of targeting a signaling molecule responsible for tumor growth. This novel targeted therapy in combination with chemotherapy can benefit a patient population that otherwise carries a poor prognosis.
Intellectual Property
Patent Application Filed
Licensing Opportunity
This technology is available for exclusive licensing and/or collaborative co-development.